Add BrightSurf on Google Email

Optimal lifting of COVID-19 restrictions would follow pace of vaccination, study suggests

A new analysis suggests that the pace of vaccination should directly dictate the lifting of COVID-19 restrictions to boost freedoms and minimize new waves of infection. The study's findings suggest that further severe waves can be avoided if restrictions are lifted no faster than the pace dictated by vaccination progress.

SourcePLOS·JournalPLOS Computational Biology·TypeData/statistical analysis·DateSep 2, 2021

The Lancet Infectious Diseases: COVID-19 vaccines are effective at reducing severe illness and hospitalisation, new UK study confirms

A large-scale UK study confirms that COVID-19 vaccines are effective in reducing severe illness and hospitalisation. The study found that people who received one or two vaccine doses had lower odds of severe disease or hospitalisation than unvaccinated individuals, with a significant reduction in long COVID cases.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·TypeObservational study·DateSep 1, 2021

COVID-19 vaccine hesitancy among patients in two urban emergency departments

A study of over 1,000 patients in Philadelphia's emergency departments found that vaccine hesitancy is common among this population, driven by concerns about safety and research. The authors suggest that EDs can play a valuable role in addressing vaccine hesitancy through targeted education and outreach efforts.

SourceSociety for Academic Emergency Medicine·JournalAcademic Emergency Medicine·TypeSurvey·DateAug 31, 2021

Report: Autistic individuals have increased risk of COVID-19

Research from Drexel University's Autism Institute identifies higher odds of living in residential facilities, receiving outside caregiver services, and having high-risk health conditions among autistic adults, as well as those with intellectual disability and mental health diagnoses. These groups are more likely to contract COVID-19 a...

SourceDrexel University·JournalAutism·DateAug 30, 2021

COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants

Researchers at Washington University School of Medicine found that COVID-19 vaccination elicited a response in nearly nine out of ten people with weakened immune systems. However, the responses were only about one-third as strong as those mounted by healthy people. Despite this, the discovery is encouraging news for a population at hig...

SourceWashU Medicine·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateAug 30, 2021

Pfizer jab side effects in 12-15 year olds at high risk of COVID-19 complications, mild to moderate

A small study of 27 children aged 12-15 with neurological conditions found the Pfizer jab's side effects were mild to moderate and cleared up within a week. The vaccination was taken by parents who believed their children were at high risk of COVID-19 disease, highlighting its benefits in vulnerable groups.

SourceBMJ Group·JournalArchives of Disease in Childhood·TypeObservational study·DateAug 26, 2021

Largest real-world study of COVID-19 vaccine safety published by Israel's Clalit Research Institute in The New England Journal of Medicine

A large-scale analysis of Israel's COVID-19 vaccination data found that the Pfizer/BioNTech BNT162B2 vaccine is very safe, with only a few potential side effects. The study also revealed that coronavirus infection poses a much higher risk of serious adverse events compared to vaccination.

SourceClalit Research Institute·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateAug 25, 2021

Individualistic COVID-19 vaccine messages had best effect in US study

A US study published in Journal of Health Communication found that emphasizing individual health risks from COVID-19 leads to higher vaccine acceptance among participants. The researchers also discovered that loss framing was slightly more effective than positive gain framing, suggesting cultural and personal factors may play a role.

SourceWashington State University·JournalJournal of Health Communication·TypeExperimental study·DateAug 24, 2021

How well did the EU respond to the first wave of the Covid-19 pandemic? Experts now give their verdict

A review of expert opinions reveals mixed results for the EU's COVID-19 response, with successes including coordinated vaccine procurement but shortcomings including inconsistent national responses. Experts emphasize the need for strengthened local surveillance systems and improved EU leadership to prevent similar crises.

SourceFrontiers·JournalFrontiers in Public Health·TypeSurvey·DateAug 20, 2021

CDC’s “honor system” mask guidance threatened vulnerable communities

A CDC mask guidance update in May 2021 ignored realities that left vulnerable communities exposed to increased transmission of COVID-19. The guidance relied on the honor system to ensure unvaccinated individuals wore masks, but experts say this approach was flawed due to lack of verification methods.

SourceMassachusetts General Hospital·JournalJournal of General Internal Medicine·TypeCommentary/editorial·DateAug 12, 2021

New COVID-19 vaccine moves ahead

A South Australian-developed SARS-CoV-19 vaccine has shown promising results in early animal testing, confirming its safety and effectiveness in preventing COVID-19 lung infection. The vaccine, named COVAX-19, incorporates an adjuvant derived from a plant sugar called inulin.

SourceFlinders University·JournalVaccine·TypeExperimental study·DateAug 11, 2021

A COVID-19 vaccine strategy to give the body ‘border protection’

A new research strategy enhances COVID-19 vaccine effectiveness by providing 'border protection' immunity in the nose, mouth and blood. The approach involves suppressing an enzyme that breaks down both pathogens and immune cells, resulting in a robust antibody response and improved protection against infections.

SourceOhio State University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 11, 2021

Covid-19 booster jab in the autumn will offer better protection against variants of concern, suggests new study

Researchers found that a second dose of the Pfizer vaccine, especially in those with previous SARS-CoV-2 infection, dramatically increased virus variant neutralising antibody responses. This additional boost increases potential protection against existing and future variants of concern.

SourceUniversity of Nottingham·JournalScience Translational Medicine·TypeObservational study·DateAug 10, 2021

Organ transplant recipients significantly protected by COVID-19 vaccination

A recent study published in Transplant Infectious Disease found that COVID-19 vaccination provides strong protection against the virus for solid organ transplant recipients, with an almost 80% reduction in symptomatic cases. The study examined data from over 2,150 transplant patients and showed that nearly 70% of vaccinated patients re...

SourceUniversity of California - San Diego·JournalTransplant Infectious Disease·DateAug 5, 2021

More variants TLR7 gene found in young healthy men with severe Covid-19

Researchers found two new TLR7 gene variants in young, healthy men with severe Covid-19, highlighting the importance of genetic screenings for early intervention. These variants were associated with impaired immune response and increased risk of serious illness, emphasizing the need for preventive vaccination strategies.

SourceRadboud University Medical Center·JournalFrontiers in Immunology·TypeCase study·DateAug 3, 2021

New model shows how cities can safely lift COVID-19 restrictions

A new model developed by NYU Tandon School of Engineering researchers provides a data-centric approach to reopening towns and can serve as a blueprint for areas with low vaccine rates. The model shows that increasing access to social gatherings and public transportation at a certain rate supports a safe, rapid reopening.

SourceNYU Tandon School of Engineering·JournalAdvanced Theory and Simulations·TypeComputational simulation/modeling·DateAug 2, 2021

Combined effects of masking and distance on aerosol exposure potential

Researchers at Mayo Clinic found that wearing masks and maintaining physical distance significantly reduce the spread of COVID-19. The study showed that both disposable paper medical masks and two-layer cloth masks were effective in blocking aerosol particles, with increased distance reducing particle counts to near baseline levels.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateJul 29, 2021

The mechanics of puncture finally explained

Researchers developed a mechanical theory to determine the critical force required for needle insertion in soft materials like skin, discovering that tissue toughness and needle radius play crucial roles. The model provides quantitative predictions and may impact future technology like self-administered disposable pads with microneedles.

SourceUniversity of British Columbia·JournalJournal of the Mechanics and Physics of Solids·DateJul 26, 2021

COVID-19 news from Annals of Internal Medicine

Researchers found that COVID-19 vaccines are more than 95% effective in preventing confirmed infection. The study also revealed significant disparities among different age groups and comorbidities, with higher risks observed among older adults and those with underlying health conditions. Additionally, a separate cohort study showed tha...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateJul 20, 2021